PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.\', \'Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA.\', \'Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.\', \'Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA.\', \'Department of Surgery, Duke University School of Medicine, Durham, NC, USA.\', \'Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1126/scitranslmed.abj7125
?:hasPublicationType
?:journal
  • Science translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 34726473
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 9.7
?:rankingScore_hIndex
  • 147
is ?:relation_isRelatedTo_publication of
?:title
  • A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34726473>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34726473>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all